Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 127

1.

Lipodystrophy and inflammation predict later grip strength in HIV-infected men: the MACS Body Composition substudy.

Crawford KW, Li X, Xu X, Abraham AG, Dobs AS, Margolick JB, Palella FJ, Kingsley LA, Witt MD, Brown TT.

AIDS Res Hum Retroviruses. 2013 Aug;29(8):1138-45. doi: 10.1089/AID.2013.0020. Epub 2013 May 2.

2.

Fat distribution and longitudinal anthropometric changes in HIV-infected men with and without clinical evidence of lipodystrophy and HIV-uninfected controls: a substudy of the Multicenter AIDS Cohort Study.

Brown TT, Xu X, John M, Singh J, Kingsley LA, Palella FJ, Witt MD, Margolick JB, Dobs AS.

AIDS Res Ther. 2009 May 13;6:8. doi: 10.1186/1742-6405-6-8.

3.

Assessment of growth hormone dynamics in human immunodeficiency virus-related lipodystrophy.

Rietschel P, Hadigan C, Corcoran C, Stanley T, Neubauer G, Gertner J, Grinspoon S.

J Clin Endocrinol Metab. 2001 Feb;86(2):504-10.

PMID:
11158000
4.
5.

Hyperandrogenemia in human immunodeficiency virus-infected women with the lipodystrophy syndrome.

Hadigan C, Corcoran C, Piecuch S, Rodriguez W, Grinspoon S.

J Clin Endocrinol Metab. 2000 Oct;85(10):3544-50.

PMID:
11061499
6.

The association of lipodystrophy and oxidative stress biomarkers in HIV-infected men.

Vassimon HS, Deminice R, Machado AA, Monteiro JP, Jordao AA.

Curr HIV Res. 2010 Jul;8(5):364-9.

PMID:
20353389
7.

Increased abdominal visceral fat is associated with reduced bone density in HIV-infected men with lipodystrophy.

Huang JS, Rietschel P, Hadigan CM, Rosenthal DI, Grinspoon S.

AIDS. 2001 May 25;15(8):975-82.

PMID:
11399979
8.

Association of severe insulin resistance with both loss of limb fat and elevated serum tumor necrosis factor receptor levels in HIV lipodystrophy.

Mynarcik DC, McNurlan MA, Steigbigel RT, Fuhrer J, Gelato MC.

J Acquir Immune Defic Syndr. 2000 Dec 1;25(4):312-21.

PMID:
11114831
9.
10.

Serum adipocytokines are related to lipodystrophy and metabolic disorders in HIV-infected men under antiretroviral therapy.

Vigouroux C, Maachi M, Nguyên TH, Coussieu C, Gharakhanian S, Funahashi T, Matsuzawa Y, Shimomura I, Rozenbaum W, Capeau J, Bastard JP.

AIDS. 2003 Jul 4;17(10):1503-11.

PMID:
12824788
11.

Fat distribution is altered in HIV-infected men without clinical evidence of the HIV lipodystrophy syndrome.

Kosmiski L, Kuritzkes D, Hamilton J, Sharp T, Lichtenstien K, Hill J, Eckel R.

HIV Med. 2003 Jul;4(3):235-40.

12.

Fasting hyperinsulinemia in human immunodeficiency virus-infected men: relationship to body composition, gonadal function, and protease inhibitor use.

Hadigan C, Corcoran C, Stanley T, Piecuch S, Klibanski A, Grinspoon S.

J Clin Endocrinol Metab. 2000 Jan;85(1):35-41.

PMID:
10634360
13.

Tumor necrosis factor alpha is associated with insulin-mediated suppression of free fatty acids and net lipid oxidation in HIV-infected patients with lipodystrophy.

Haugaard SB, Andersen O, Pedersen SB, Dela F, Fenger M, Richelsen B, Madsbad S, Iversen J.

Metabolism. 2006 Feb;55(2):175-82.

PMID:
16423623
15.

Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals.

Brown TT, Chen Y, Currier JS, Ribaudo HJ, Rothenberg J, Dubé MP, Murphy R, Stein JH, McComsey GA.

J Acquir Immune Defic Syndr. 2013 Jul 1;63(3):323-30. doi: 10.1097/QAI.0b013e318295eb1d.

16.

Hypermetabolism and altered substrate oxidation in HIV-infected patients with lipodystrophy.

Vassimon HS, de Paula FJ, Machado AA, Monteiro JP, Jordão AA Jr.

Nutrition. 2012 Sep;28(9):912-6. doi: 10.1016/j.nut.2011.12.010. Epub 2012 Apr 13.

PMID:
22503533
17.
18.

Fat distribution and metabolic changes are strongly correlated and energy expenditure is increased in the HIV lipodystrophy syndrome.

Kosmiski LA, Kuritzkes DR, Lichtenstein KA, Glueck DH, Gourley PJ, Stamm ER, Scherzinger AL, Eckel RH.

AIDS. 2001 Oct 19;15(15):1993-2000.

PMID:
11600828
19.

Proinflammatory markers, insulin sensitivity, and cardiometabolic risk factors in treated HIV infection.

Samaras K, Gan SK, Peake PW, Carr A, Campbell LV.

Obesity (Silver Spring). 2009 Jan;17(1):53-9. doi: 10.1038/oby.2008.500. Epub 2008 Nov 13.

20.

Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.

Koutkia P, Canavan B, Breu J, Torriani M, Kissko J, Grinspoon S.

JAMA. 2004 Jul 14;292(2):210-8.

PMID:
15249570

Supplemental Content

Support Center